Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and Ischemia Reperfusion
NCT00315510Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Apr 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00315510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315510.